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Several lines of evidence have implicatedmembers of the devel-
opmentally important T-box gene family in cell cycle regulation
and in cancer. Importantly, the highly related T-box factors Tbx2
and Tbx3 can suppress senescence through repressing the cyclin-
dependent kinase inhibitors p19ARF and p21WAF1/CIP1/SDII. Fur-
thermore, Tbx2 is up-regulated in several cancers, including
melanomas where it was shown to function as an anti-senes-
cence factor, suggesting that this may be one of themechanisms
by which T-box proteins contribute to the oncogenic process.
However, very little is known about whether Tbx2 is regulated
by p21-mediated stress-induced senescence signaling pathways.
In this study, using the MCF-7 breast cancer cell line known to
overexpress Tbx2, we show that in response to stress induced by
ultraviolet irradiation the Tbx2 protein is specifically phospho-
rylated by the p38mitogen-activated protein kinase. Using site-
directed mutagenesis and in vitro kinase assays, we have identi-
fied serine residues 336, 623, and 675 in the Tbx2 protein as the
p38 target sites and show that these sites are phosphorylated in
vivo. Importantly, we show by Western blotting, immunofluo-
rescence, and reporter assays that this phosphorylation leads to
increasedTbx2protein levels, predominant nuclear localization
of the protein, and an increase in the ability of Tbx2 to repress
the p21WAF1/CIP1/SDII promoter. These results show for the first
time that the ability of Tbx2 to repress the p21 gene is enhanced
in response to a stress-induced senescence pathway,which leads
to a better understanding of the regulation of the anti-senes-
cence function of Tbx2.
The T-box gene family encodes transcription factors that are
evolutionarily defined by the conservation of the DNA-binding
domain known as the T-box (1–4). This family has achieved
great prominence in the field of developmental biology because
itsmembers have been shown to play important roles in embry-
onic development (5) and mutations within several T-box
genes are associated with a number of human congenital dis-
eases (6). Furthermore, members of the T-box family have also
been implicated in cell cycle regulation and cancer. Tbx2 and
the highly related factor Tbx3 function as transcriptional
repressors (7–10) and can prevent senescence inmouse embry-
onic fibroblasts and ST.HdhQ111 striatal cells through a mech-
anism involving their ability to repress the cyclin-dependent
kinase inhibitors p19ARF (11–13) and p21WAF1/CIP1/SDII
(referred to as p21) (14, 15). BothTbx2 andTbx3 have also been
linked to several cancers, primarily because their expression
levels have been found to be deregulated in these cancers. Tbx2
and Tbx3 are required for normal breast development, and
their expression was found to be up-regulated in a subset of
human breast tumors and breast cancer cell lines (16, 17). Both
these factors are also overexpressed in a subset of pancreatic
cancers (18, 19) and melanomas (15, 20). In addition, Tbx3 has
been implicated in bladder (21), liver, (22) and ovarian cancers
(23). One mechanism by which Tbx3 may be involved in onco-
genesis has been suggested by a study that showed that Tbx3
can cooperate with oncogenic Myc and Ras to induce cellular
transformation and suppress apoptosis through repression of
p19ARF expression and p53 protein levels (24). It is also possible
that Tbx2 and Tbx3 may contribute to the oncogenic process
through their anti-senescence function, especially since a dom-
inant negative form of Tbx2 has been shown to induce senes-
cence inmelanomas overexpressing Tbx2 (15). Taken together,
the above reports would suggest that the levels of Tbx2 and
Tbx3 need to be tightly regulated during the cell cycle. Indeed a
recent study by Bilican and Goding (25) showed that Tbx2 pro-
tein levels are regulated during the various phases of the cell
cycle, peaking at G2. In the same study the investigators show
that changes in Tbx2 protein levels are notmatched by changes
in Tbx2 mRNA levels, suggesting that the protein may be reg-
ulated by post-translational modifications such as phosphoryl-
ation. Identifying signaling pathways, especially those involved
in inducing senescence, that regulate Tbx2 levels and activity is
therefore potentially important for the development of novel
therapeutic targets to treat cancers by inhibitingTbx2 function.
Cellular senescence can be triggered by alterations of
telomeres as well as in response to a variety of stresses, such as
DNA damage caused by irradiation and cytotoxic drugs or
chemically induced oxidative stress (26). The p38 pathway
plays an important role in diverse cellular responses such as cell
cycle progression, differentiation, and apoptosis (27) and has
also been identified as a senescence signaling pathway that is
activated in response to both telomere-dependent and -inde-
pendent senescence (28–30). In response to DNA damaging
agents, such as ultraviolet (UV) radiation, the p38 mitogen-
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activated protein (MAP)3 kinase signal transduction cascade is
initiated to inhibit cell cycle progression and to activate DNA
repair processes, thereby maintaining the integrity of the
genome. It has previously been shown that in response to stress,
p38 phosphorylates and stabilizes the p21 protein (31), which is
thought to be the major mediator of a senescence-like growth
arrest after UV-induced DNA damage. The subsequent role
and regulation of p21 in the DNA repair pathway is, however,
unresolved. One line of evidence suggests that p21 levels are
induced and that high levels of the protein are maintained in
order to facilitate the effect of proliferating cell nuclear antigen in
DNA repair (32, 33). However, another line of evidence suggests
that the activation of p21 is only transient and that p21 expression
needs to decrease after the establishment of growth arrest in order
to promote DNA repair by facilitating proliferating cell nuclear
antigen recruitment to DNA repair sites (34–36). Although there
is compelling evidence to suggest that the decrease in p21 levels
seen in the latter scenario results from ubiquitin-dependent pro-
tein degradation (36), there is also evidence to suggest that a
decrease in p21mRNA levels may be involved (37).
Here we show that in response to ultraviolet C (UVC) irradi-
ation, Tbx2 is specifically phosphorylated by the p38 MAP
kinase,which leads to an increase inTbx2protein levels, predom-
inant nuclear localization of Tbx2, and an increase in the ability of
Tbx2 to repress the p21 promoter. Furthermore, in response to
UVC irradiation the increase in Tbx2 protein levels correlates
inversely with p21 protein and mRNA levels. Taken together, the
data suggest a possiblemechanismbywhich p21mRNA levels are
repressed in response to UV-induced DNA damage.
EXPERIMENTAL PROCEDURES
Plasmids—The wild-type (WT) p21-LUC reporter construct
contains a 2.2-kb SacI-Hind III fragment of the human p21
promoter inserted upstream of a LUC reporter gene (38). As
has previously been described, the pCMV19.Tbx2 and
pGEX.Tbx2 were constructed by cloning a full-length BamHI
fragment of the mouse Tbx2 cDNA into the BamHI site of the
pCMV19a and pGEX.2TK vectors (7). The pGL3-Basic-p14ARF
(642) luciferase construct was kindly provided by Dr. D. Holzs-
chu (Ohio University, Athens, Ohio). Point mutations were
introduced into full-length WT Tbx2 cDNA by site-directed
mutagenesis using the Stratagene QuikChange system and
appropriate primer pairs.
Cell Cultures and Transfection Assay—COS-7 monkey kid-
ney, NIH 3T3 mouse fibroblast, and HT1080 human fibrosar-
coma cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum, 200
units/ml penicillin, and 100 g/ml streptomycin. MCF-7,
human breast epithelial adenocarcinoma cells, were cultured in
RPMI 1640 supplemented with 10% fetal bovine serum, 1 mM
sodium pyruvate, 0.1 mM minimal essential medium non-es-
sential amino acids, and 0.01 mg/ml insulin. Cells were main-
tained in a 37 °C incubator (95.0% air/5% CO2, 65% humidity).
Transfections were performed using FuGENE 6 (Roche
Applied Science) and/or FuGENEHD (Roche Applied Science)
for COS-7 cells and Transfectin (Bio-Rad) for NIH 3T3 cells,
according to the manufacturers’ instructions. Cells were plated
at 0.5  105/ml in 35-mm dishes 1 day before transfection. For
luciferase assays, COS-7 cells were transfected with 700 ng of
the p21 or p14ARF luciferase reporter plasmid plus 200 ng of the
Tbx2 expression plasmid or 200 ng of an empty vector plasmid.
The vector pRL-TK containing the thymidine kinase promoter
driving the expression of aRenilla reporterwas used as an inter-
nal control for transfection efficiency (50 ng/transfection).
Cells were cultured for 30 h, and extracts were assayed for fire-
fly and Renilla luciferase activity using the dual luciferase assay
system (Promega, Madison, WI). Luciferase activities were
measured using the Luminoskan Ascent luminometer
(Thermo Labsystems, Franklin, MA). Firefly luciferase values
were normalized to theRenilla luciferase activity and expressed
relative to empty vector control. All transfections were per-
formed in duplicate, and at least three independent experi-
ments were done to confirm reproducibility. For transfected
cells, UVC irradiation (254 nm, 40 J/m2) was performed using a
UV Stratalinker 1800 apparatus (Stratagene) 30 h post-trans-
fection. For cells expressing endogenousTbx2,UVC irradiation
was performed at 100 J/m2. For UVC treatment, the medium
was completely removed and replaced immediately after irra-
diation. Pretreatment with the specific p38 inhibitor SB203580
(Calbiochem)was at 10M for 30min prior toUVC irradiation.
Quantitative Real-time PCR—Total RNAwas extracted from
MCF-7 cells using the RNeasy Plus Mini kit (Qiagen). Reverse
transcription of RNA (1 g) was performed according to the
manufacturer’s instructions using the QuantiTect Reverse
Transcription kit (Qiagen). Using 2 l of cDNA, PCR was con-
ductedwith theQuantiTect SYBRGreen PCRmastermix (Qia-
gen) according to the manufacturers’ protocol. Real-time PCR
was performed on a LightCycler Version 3 (Roche Applied Sci-
ence) using the following parameters: denaturation (15 min at
95 °C), annealing and amplification at 35 cycles (15 s at 94 °C;
20 s at 55 °C; 20 s at 72 °C), melting temperature (15 s at 65 °C),
and a cooling step (30 s at 40 °C). Each DNA sample was quan-
tified in duplicate, and a negative control without cDNA tem-
plate was run with every assay to assess the overall specificity.
Melting curve analyses were carried out to ensure product
specificity, and data were analyzed using the 2Ct method
(39). RelativemRNA expression levels were normalized to glyc-
eraldehyde-3-phosphate dehydrogenase for each reaction with
PCR efficiency correction calculated using the formula Ratio 
(Etarget)CPtarget(controlsample)/(Eref)CPref(controlsample). E, real-
time PCR efficiency, CP, crossing-point. Primers used to amplify
thehumanTbx2 (QT00091266)andp21 (QT00062090)werepur-
chased from Qiagen. Glyceraldehyde-3-phosphate dehydrogen-
ase, forward 5-GAAGGCTGGGGCTCATTT-3; reverse
5-CAGGAGGCATTGCTGATGAT-3).
Western Blot Analyses—Whole cell extracts were prepared
from cells using a lysis buffer containing 150 mM NaCl, 1%
Triton X-100, 0.1% SDS, 10 mM Tris-HCl, pH 7.5, 1% deoxy-
cholate, supplemented with 1 mg/ml aprotinin, 1 mg/ml pep-
statin A, and 2 mM phenylmethanesulfonyl fluoride protease
inhibitors (Sigma). Proteins were resolved on 7.5–15% SDS-
3 The abbreviations used are: MAP, mitogen-activated protein; UVC, ultravio-
let C; WT, wild-type; FBS, fetal bovine serum; GST, glutathione S-transfer-
ase; NLS, nuclear localization signal; MOPS, 4-morpholinepropanesulfonic
acid; JNK, c-Jun N-terminal kinase.
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polyacrylamide gels as required and transferred toHybondECL
(Amersham Biosciences). The membranes were probed with
appropriate primary antibodies and detected using peroxidase-
conjugated anti-mouse or anti-rabbit antibodies (1:5000) and
visualized by ECL (Pierce). The primary antibodies used were
mouse monoclonal anti-Tbx2 62–2 antibody (1:2000), rabbit
polyclonal anti-phospho-p38 (1:1000) and anti-p38 (1:5000)
(Cell Signaling Technology Inc., Beverly, MA), anti-Pk-Tag
(SV5) antibody (1:3000) (Serotec, Oxford, UK), and rabbit poly-
clonal p21 (1:200) and mouse monoclonal -tubulin (1:500)
from Santa Cruz Biotechnology, Santa Cruz, CA.
Protein Expression and Purification—All glutathione
S-transferase fusion proteins were expressed in Escherichia
coli strain pLysS. Isopropyl-1-thio-D-galactopyranoside
induction was performed for 4 h at 37 °C. Fusion proteins
were purified using glutathione-Sepharose 4B beads (Amer-
sham Biosciences).
p38 Protein Kinase Assays—Recombinant active p38 was
obtained from Upstate Biotechnology. Kinase assays were per-
formed in 40 l of reaction volume (20 mM MOPS, pH 7.2, 25
mM -glycerophosphate, 5 mM EGTA, 1 mM sodium
orthovanadate, 1 mM dithiothreitol) at 30 °C for 30 min under
agitation. 25 ng of active p38 protein kinasewere added toTbx2
recombinant protein in the presence of [-32P]ATP (10 M Ci
diluted with 9 l of 400 M unlabeled ATP, 75 mM MgCl2) and
incubated for 30 min at 30 °C. Following the kinase reaction,
beads were washed five times with 1 ml of reaction buffer, and
20l of protein denaturing buffer were added. Phosphorylation
of Tbx2 by the p38 MAP kinase was detected by autoradiogra-
phy after SDS-PAGE gel electrophoresis.
Immunofluorescence—MCF-7 cells grown on glass coverslip
slides 1 h after UVC irradiation were washed with phosphate-
buffered saline and fixed with 4% paraformaldehyde for 20 min
at room temperature before permeabilization with 0.2% Triton
X-100 for 10 min at room temperature. Slides were incubated
overnight at 4 °Cwithmouse Tbx2monoclonal antibody (62-2)
at a dilution of 1:750 and then incubated with Alexa 488 goat
anti-mouse IgG (Molecular Probes, Eugene,OR) at a dilution of
1:1000 for 2 h at room temperature. Cells were incubated in the
dark with 1 g/ml 4,6-diamidino-2-phenylindole in phos-
phate-buffered saline for 10 min, mounted on a slide with
Mowial mounting medium (Hoescht, Germany) containing
anti-fade (Sigma), and examined by fluorescent microscopy.
RESULTS
Tbx2 Is Phosphorylated in Vivo—To determine whether the
Tbx2 protein is regulated post-translationally by phosphoryla-
tion, protein extracts from MCF-7 cells were treated with
shrimp alkaline phosphatase and subjected to Western blot
analyses. Fig. 1A shows that when probed with an antibody
specific to the Tbx2 protein, the higher molecular weight band
seen in the untreated sample disappears in the phosphatase-
treated sample. These results suggest that the top band seen in
the untreated sample represents phosphorylated Tbx2 and that
the protein is phosphorylated in vivo.
UVC-induced Phosphorylation of Tbx2—Having established
that Tbx2 is phosphorylated in vivo, we next examined the
Tbx2 protein sequence for potential phosphorylation sites
using an on-line motif data base (au.expasy.org/tools/scan-
prosite/). Thirteen serine-proline (SP) motifs (Fig. 1B), which
are minimum potential target sites for phosphorylation by sev-
eral kinases, includingmembers of theMAPkinase family, were
identified (40). To investigate whether Tbx2 is a target for
stress-responsive kinase(s), COS-7 cells were transfectedwith a
Tbx2 expression vector and exposed to increasing doses of
UVC irradiation and protein extracts were analyzed by West-
ern blotting. Fig. 2A shows that with increasing doses of UVC
irradiation there is an increase in phosphorylated Tbx2 from 10
J/m2. This observed increase in phosphorylatedTbx2 is consist-
ent with the appearance of activated p38, as detected using an
antibody specific for phosphorylated p38. To investigate
whether there was a similar effect of UVC irradiation on the
phosphorylation status of endogenous Tbx2, MCF-7 cells were
exposed to a fixed dose of 100 J/m2 UVC and protein harvested
at the indicated time points post-treatment (Fig. 2B). An
increase in the phosphorylation status of Tbx2 was observed
immediately after UVC radiation, with high levels persisting up
to 180 min post-treatment. It is interesting to note that this
effect is also seen for the lower Tbx2 band which, at the early
time points, is probably due to post-translational modifica-
tion(s) rather than post-transcriptional event(s). The dose of
UVC irradiation selected in this experiment was based on pre-
vious results that showed that it consistently yielded high levels
of phosphorylated Tbx2 inMCF-7 cells (data not shown). Both
the JNK and p38 MAP kinase pathways are strongly activated
by a variety of cellular stresses, including UV irradiation (41).
To identify which of the two pathwayswas responsible for Tbx2
phosphorylation, we exposed cells to 100 J/m2 UVC irradiation
in the presence or absence of SB203580, which specifically
inhibits p38 while being ineffective against JNK. Based on ear-
lier results, protein was harvested 60min post-UVC irradiation
and analyzed by Western blotting. The results show that the
UVC-induced increase in Tbx2 phosphorylation is specifically
via the p38MAP kinase, as treatment with the SB203580 inhib-
itor significantly reduces this effect (Fig. 2C). We next investi-
gated the effect of UVC irradiation on Tbx2 mRNA levels by
FIGURE 1. Tbx2 is phosphorylated in vivo. A, dephosphorylation of Tbx2 by
shrimp alkaline phosphatase. Protein extracts (30 g) from MCF-7 cells were
dephosphorylated by incubating the samples with 1 unit of shrimp alkaline
phosphatase at 37 °C for 30 min prior to Western blot analyses. For optimal
separation of phosphorylated Tbx2, protein extracts were separated by 7.5%
SDS-PAGE. Tubulin is included as a loading control. p-Tbx2, phosphorylated
Tbx2. B, schematic representation of Tbx2 showing the thirteen SP motifs that
are potential phosphorylation sites.
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quantitative real-timePCR. RNAextracted fromMCF-7 cells at
0, 30, and 60 min post-UVC irradiation was amplified using
primers specific for Tbx2, and Fig. 2D shows that Tbx2mRNA
levels increased immediately post-UVC irradiation with levels
peaking at 30 min. Taken together, these results suggest that
Tbx2 protein levels increase in response toUVC irradiation due
to both a phosphorylation-dependent increase in the stability of
the protein and an increase in mRNA levels.
Tbx2 Is Phosphorylated by the p38MAP Kinase at Three Ser-
ine Residues—To map the p38 phosphorylation sites, each of
the thirteen candidate SP sites previously identified in the Tbx2
protein was individually mutated to alanine by site-directed
mutagenesis. These proteins were expressed with a glutathione
S-transferase tag and were used as substrates for in vitro p38
kinase assays. In these kinase assays the GST-Tbx2 fusion pro-
teins were expressed as either N-terminal (1–371) or C-termi-
nal (371–711) proteins (Fig. 3A). Glutathione S-transferase
alone was used as a negative control. The results (Fig. 3B) indi-
cate that theWTGST-Tbx2 fusion proteins (1–371) and (371–
711) were both phosphorylated by
the p38 MAP kinase. Although
S192A and S342A had no effect on
phosphorylation of the N-terminal
portion of Tbx2, the S336A muta-
tion abolished phosphorylation by
the p38 kinase. The single muta-
tions S623A and S675A reduced
phosphorylation of the C terminus
of Tbx2, and when both these sites
were mutated, phosphorylation was
severely reduced. Mutating the
remaining eight potential p38 sites
in the C terminus of Tbx2 had no
effect on the phosphorylation of
Tbx2 in these experiments (data not
shown). These results show that
Tbx2 is phosphorylated specifically
by the p38 MAP kinase at Ser-336,
Ser-623, and Ser-675 in vitro. To
test whether these sites were phos-
phorylated in vivo, COS-7 cells were
transfected with vectors expressing
either SV5-tagged WT Tbx2 or a
SV5-tagged Tbx2 S336A,S623A,
S675A mutant, and the Tbx2 phos-
phorylation status was compared by
Western blot analyses (Fig. 3C).
Compared with WT Tbx2, which is
expressed as two bands, the Tbx2
mutant is expressed as a single band
that migrates with the lower WT
Tbx2 band. These results suggest
that serine residues 336, 623, and
675 are indeed targets for in vivo
phosphorylation. Given that mutat-
ing these three serine residues
results in the complete loss of the
upper phosphorylated band, it
would imply that they are critical for phosphorylation by an
additional kinase(s). We next investigated whether these resi-
dues were phosphorylated in response to UVC irradiation.
Cells were transfected with vectors expressing either SV5-
taggedWTTbx2 or the SV5-tagged Tbx2 S336A,S623A,S675A
mutant in the presence or absence of UVC, and the Tbx2 phos-
phorylation status was compared byWestern blot analyses (Fig.
3D). As expected, the intensity of both WT Tbx2 bands
increased in response to UVC irradiation. Mutating the serine
residues 336, 623, and 675, however, abolished this effect
because only a single band was observed in both treated and
untreated samples. These results confirmed that the identified
sites were the only p38 targets for phosphorylation of Tbx2 in
response to UVC irradiation.
UVC-induced Phosphorylation by p38 Affects Tbx2 Protein
Stability and Subcellular Localization—To explore the func-
tional significance of Tbx2 phosphorylation by p38, we first
investigated its effect on Tbx2 protein stability. This was
achieved bymutating the p38 target sites to either alanine (Ala),
FIGURE 2. UVC-induced phosphorylation of Tbx2. A, dose-dependent increase in the phosphorylation status
of transfected Tbx2 in response to UVC irradiation. COS-7 cells were transfected with a vector expressing SV5
epitope-tagged Tbx2 and UVC irradiated at the indicated dosages. Protein extracts were prepared 1 h post-
treatment. To detect phosphorylated Tbx2, protein samples were analyzed on a 7.5% SDS-PAGE and by West-
ern blotting using an antibody to SV5. Levels of phospho-p38 and total p38 in these samples were assessed on
a 12% SDS-PAGE and by Western blotting with appropriate antibodies. The bar graph compares the intensity
of the upper and lower bands in each sample normalized to the p38 loading control. B, time-dependent increase
in the phosphorylation of endogenous Tbx2 in response to UVC irradiation. Protein extracts from MCF-7 cells at
the indicated time points post-UVC irradiation (100 J/m2) were assayed as described in panel A. The proteins
extracted from 0 to 30 min and 60 to 300 min post-UVC treatment were from different experiments and were
therefore analyzed on separate gels. C, endogenous Tbx2 is phosphorylated in vivo by the p38 kinase. MCF-7
cells irradiated with UVC (100 J/m2) in the presence or absence of SB203580 (10 M, 30 min prior to UVC
irradiation), a highly specific inhibitor of the p38 family kinases. Protein extracts were assayed as described in
panel A. D, Tbx2 mRNA levels increase in response to UVC irradiation. Quantitative real-time PCR of endogenous
Tbx2 mRNA extracted from MCF-7 cells was performed at the indicated times post-UVC irradiation (100 J/m2).
The levels of Tbx2 mRNA expression were normalized against glyceraldehyde-3-phosphate dehydrogenase.
Error bars represent standard deviations.
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to abolish phosphorylation, or glutamic acid (Glu), to mimic
phosphorylation. NIH 3T3 cells, transiently transfected with
either WT Tbx2 or the Tbx2 mutants, were incubated with
cycloheximide, a protein synthesis inhibitor, over a period of
6 h (Fig. 4A). To accurately quantify total levels of Tbx2 protein,
cell lysates were separated on a 10% SDS-PAGE in this experi-
ment, and hence Tbx2 is detected as a single band. The Tbx2
S336A,S623A,S675A mutant protein was unstable with an
approximate 30% decrease in protein levels at 6 h. On the other
hand, levels of the pseudo-phosphorylated Tbx2 S336E,
S623E,S675E mutant and WT Tbx2 proteins remain
unchanged. This finding implicates p38 kinase as a modulator
of Tbx2 protein stability in response to cellular stress.
We next wished to establish by means of immunofluores-
cence whether phosphorylation by the p38 MAP kinase in
response to UVC irradiation affected the subcellular localiza-
tion of Tbx2 (Fig. 4B). Endogenous Tbx2 was found to exhibit
diffuse staining in both the cytoplasm and nucleus of themock-
irradiated cells. In MCF-7 cells exposed to UVC irradiation,
however, Tbx2 was predominantly localized in the nuclei of
cells. Furthermore, in cells pretreated with the SB203580 p38
kinase inhibitor this effect was reversed as staining was
obtained in both the cytoplasmandnucleus. These results show
that phosphorylation of Tbx2 by the p38 kinase in response to
UVC irradiation results in the trans-
location of the protein to the
nucleus.
UVC-induced Phosphorylation by
p38 Enhances the Ability of Tbx2 to
Repress p21—Taken together, the
above results suggest that Tbx2may
be playing a role in the UV stress
pathway through repressing specific
target genes. Interestingly, p21, a
known Tbx2 target (14), has been
shown to inhibit DNA repair (34–
36) and to be down-regulated in
response to UV irradiation (36, 37,
42). This UV-mediated down-regu-
lation of p21 was previously
observed at both the protein and
mRNA levels in MCF-7 cells (37),
suggesting that UV-induced phos-
phorylation of Tbx2 may be
required to inhibit p21 in these cells.
We therefore tested this hypothesis
by investigating whether there was
an inverse correlation between
Tbx2 and p21 protein levels in
UVC-irradiated MCF-7 cells (Fig.
5A). Immediately post-UVC irradi-
ation (0 min post-UVC) there was a
significant increase in p21 protein
levels followed by a decrease that
correlated inversely with the
increase in Tbx2 protein levels at all
subsequent time points. It is impor-
tant to point out that the protein
extracted from 0 to 30 min and 60 to 300 min post UVC-treat-
ment were analyzed on different gels and this may account for
the difference in p21 protein levels seen in the untreated lanes
of the two blots. This does not, however, detract from the
results obtained. Quantitative real-time PCR results (Fig. 5B)
revealed that relative to the non-irradiated cells p21 mRNA
levels were down-regulated immediately after UVC treatment
and that this down-regulation persisted over the period post-
UVC treatment when Tbx2 protein levels went up. These
results showed an inverse correlation between Tbx2 protein
and p21mRNA levels in UVC-irradiated MCF-7 cells and sug-
gested that Tbx2 may be preventing activation of the p21 pro-
moter under these conditions.
To investigate the possibility that stress-induced phospho-
rylation by the p38 kinase potentiates the ability of Tbx2 to
repress transcription of the p21 gene, we co-transfected COS-7
cells with WT Tbx2 together with a p21 promoter-luciferase
reporter in the presence and absence of UVC irradiation (Fig.
5C). Consistent with our previously published data (14), co-
transfection with a WT Tbx2 expression vector in the absence
of UVC irradiation resulted in an2-fold repression of the p21
promoter. In the presence of UVC irradiation, however, repres-
sion of the p21 promoter byTbx2was significantly enhanced by
5-fold. Tbx2 has previously been shown to repress the p14ARF
FIGURE 3. Tbx2 is phosphorylated by the p38 MAP kinase at three serine residues. A, schematic represen-
tation of the N-terminal (1–371) and C-terminal (371–711) Tbx2 proteins used as substrates in p38 kinase
assays. B, mapping the p38 MAP kinase target sites within Tbx2. In vitro p38 kinase assays were performed using
purified GST-Tbx2 fusion proteins as substrates in the presence of the recombinant activated p38 kinase and
[-32P]ATP. Kinase assays using the indicated Tbx2 proteins are shown in the upper panels after SDS-PAGE and
autoradiography. The lower panels show the same gels stained with Coomassie Blue, indicating that equivalent
amounts of protein were used in each assay. The bar graph shows densitometric values of radioactive levels
measured for each construct in the kinase assay. C, mutating the p38 MAP kinase sites affects the phosphoryl-
ation of Tbx2 in vivo. SV5 epitope-tagged Tbx2 or the S336A,S623A,S675A mutant were expressed in COS-7
cells, and the phosphorylation status of Tbx2 was analyzed by 7.5% SDS-PAGE and by Western blotting using
an anti-SV5 antibody. D, the identified p38 target serine residues 336, 623, and 675 in the Tbx2 protein are
the only sites phosphorylated in response to UVC irradiation. Cells were transfected with SV5 epitope-
tagged WT Tbx2 or the Tbx2 S336A,S623A,S675A mutant and exposed to UVC irradiation (40 J/m2) 29 h
post-transfection. Protein extracts were prepared 1 h post-UVC treatment and analyzed by Western blot-
ting as described in Fig. 2A.
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gene (11, 13), and we therefore next tested the effect of UVC
irradiation on this repression. Fig. 5C shows that whereas Tbx2
repressed the p14ARF promoter by 6-fold, this repression was
only marginally enhanced by UVC treatment. These results
suggest that the enhancement of Tbx2 transcriptional activity
by UVC irradiation is specific for selective targets. We next
compared the transcriptional repression of the p21 promoter
by WT Tbx2 and the Tbx2 S336A,S623A,S675A mutant. The
results in Fig. 5D indicate that whereasWTTbx2 repressed the
p21 promoter, abolishing the p38 phosphorylation target sites
led to an abrogation of this ability. Taken together, these results
suggest that the identified p38 target sites do indeed play a role
in regulating the transcriptional activity of Tbx2 on the p21
promoter in response to UVC irradiation.
DISCUSSION
Despite the pivotal role that members of the T-box family
play in a wide variety of developmental processes, very little is
known about the biochemical pathways that regulate their lev-
els and transcriptional activity. In view of the detrimental con-
sequences resulting from altered levels of T-box proteins, as
seen in both developmental disorders and in certain cancers,
the need to identify such pathways is important. Here we pro-
vide several lines of evidence that Tbx2 is phosphorylated by
the p38 MAP kinase in response to stress induced by UVC
irradiation. First, we show that phosphorylation of Tbx2
increaseswith increasing doses ofUVC irradiation and that this
is reversed in the presence of the p38 inhibitor SB203580. Sec-
ond, we show that Tbx2 is phosphorylated both in vitro and in
vivo at serine residues 336, 623, and 675. Importantly, we show
that phosphorylation by the p38 MAP kinase has significant
consequences for Tbx2 function. For example, the Tbx2 pro-
tein appeared less stable when the three p38 target serine resi-
dues weremutated to block phosphorylation. This effect of p38
phosphorylation on the stability of its substrates has been
reported for the G1 proteins p53 and cyclin D1. Whereas p38
phosphorylation of p53 led to increased protein stability, phos-
phorylation of cyclin D1 by this kinase resulted in ubiquitin-de-
pendent degradation and consequently a G1 arrest (43–45).
Moreover, Tbx2 mRNA levels also increased in response to
UVC irradiation, but the mechanism(s) for this still need to be
elucidated. It is tempting to speculate that the ubiquitous
bHLH-LZ transcription factor USF-1 may be involved. Both
Tbx2 and USF-1 are expressed in melanocytes, and USF-1 has
been shown to play an important role in mediating the tanning
response induced by UV irradiation. This mechanism involves
phosphorylation of USF-1 by the p38 MAP kinase (46), result-
FIGURE 4. UVC-induced phosphorylation by p38 affects Tbx2 protein stability and subcellular localization. A, the Tbx2 S336A,S623A,S675A mutant
displays a reduced half-life compared with wild-type Tbx2 and the Tbx2 S336E,S623E,S675E mutant. NIH 3T3 cells, transiently transfected with vectors
expressing SV5 epitope-tagged Tbx2 proteins as indicated, were incubated 48 h post-transfection with 30 g/ml cycloheximide for the indicated times to block
de novo protein synthesis. To accurately detect total levels of the Tbx2 protein as a single band, cell lysates were analyzed on a 10% SDS-PAGE and by Western
blotting with anti-SV5 antibodies. The bar graph compares the intensity of the Tbx2 protein normalized to the loading control. B, p38 phosphorylation induces
nuclear translocation of Tbx2. MCF-7 cells were treated with the p38 inhibitor SB203580 prior to UVC irradiation (100 J/m2) and then analyzed 1 h post-
treatment by immunofluorescence using an anti-Tbx2 antibody. The upper and lower panels represent images captured at 40 and 100 magnifications,
respectively.
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ing in an increase of USF-1 binding to conserved E- andM-box
motifs and activation of melanogenic target genes. The Tbx2
promoter has been shown to possess anE-box (47), and itwould
be interesting to see if it is capable of responding to USF-1,
particularly in response to UV irradiation.
Importantly, we show that Tbx2 is localized to both the cyto-
plasm and nucleus, but upon UVC irradiation phosphorylation
of Tbx2 by the p38MAP kinase led to the predominant nuclear
localization of the protein. This result would suggest that the
molecular activity of Tbx2 may be controlled, in part, by regu-
lation of its subcellular localization. Interestingly, in Caenorh-
abditis elegans, tbx-2 is involved in olfactory adaptation and is
expressed in AWB, AWC, ASJ, and many pharyngeal neurons
where the protein is mostly localized to the cytoplasm, suggest-
ing that nuclear translocation may regulate its activity (48).
There are several other lines of evidence to suggest that the
transcriptional activity of T-box factors is regulated, in part, by
the regulation of their subcellular localization. For example,
certain T-box family members have been found to possess
nuclear localization signals (NLS), which may explain the shut-
tling of these proteins into the nucleus. In patients suffering
from DiGeorge syndrome, the deletion of the NLS in Tbx1 has
been shown to prevent the mutant protein from localizing to
the nucleus, resulting in haploinsufficiency of the protein (49).
Furthermore, deletion of the Tbx3 NLS, RREKRK, at amino
acids 292–297 results in mislocalization of the protein to either
perinuclear or cytoplasmic sites (9). Given the high degree of
homology between Tbx2 and Tbx3, we compared the mouse
and human Tbx2 protein sequences and found that the Tbx3
NLS was conserved at exactly the same position in the Tbx2
protein. It will be interesting to investigate whether this NLS
plays a role in shuttling Tbx2 into the nucleus and whether
phosphorylation of the protein by the p38 MAP kinase can
regulate this process or whether the latter regulates Tbx2
nuclear localization through a mechanism independent of
the NLS.
FIGURE 5. UVC-induced phosphorylation by p38 enhances the ability of Tbx2 to repress p21. A, inverse correlation between Tbx2 and p21 protein levels
in response to UVC irradiation. Protein extracts (the same used in Fig. 2B) from MCF-7 cells at the indicated time points post-UVC irradiation (100 J/m2) were
analyzed by 15% SDS-PAGE and Western blotting using an antibody to p21. The proteins extracted from 0 to 30 min and 60 to 300 min post-UVC treatment
were analyzed on different gels. The results for Tbx2, p-p38, and total p38 are the same as shown in Fig. 2B. The bar graph compares the intensity of the Tbx2,
p-p38, and p21 bands in each sample normalized to the p38 loading control. B, p21 mRNA levels are repressed in response to UVC irradiation. Total RNA was
extracted from MCF-7 cells at the times indicated post-UVC irradiation. Quantitative real-time PCR was then performed on reverse-transcribed RNA using
primers specific to p21, and mRNA levels were normalized to glyceraldehyde-3-phosphate dehydrogenase. Error bars represent standard deviations. C, UVC irradiation
enhances the transcriptional repression of p21 by Tbx2. The p21 promoter-luciferase reporter (700 ng) was co-transfected into COS-7 cells either with the empty pCMV
(200 ng) vector or a Tbx2 (200 ng) expression vector in the presence or absence of UVC (40 J/m2) and luciferase activity determined. Promoter activity is indicated as
-fold repression, which represents the ratio of the luciferase activity generated by the pCMV empty vector (without Tbx2) to that obtained in the presence of
pCMV-Tbx2. The above experiment was repeated under the same conditions using 700 ng of the p14ARF promoter-luciferase reporter. *, significant difference from the
control (no UVC treatment) at p  0.05. D, COS-7 cells were transfected as described in panel C with the Tbx2 expression vectors as indicated and luciferase activity
determined. Western blotting shows equal expression of WT Tbx2 and the Tbx2 mutant in the luciferase assays. Error bars represent standard deviations.
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The effect of UV-induced p38 phosphorylation onTbx2 pro-
tein levels and nuclear localization would suggest a role for this
transcription factor in the stress signaling pathway. There has
been a lot of controversy in the literature regarding the role and
regulation of the Tbx2 target p21 in response to UV-induced
DNA damage. The present study shows that in response to
UVC irradiation, p21 protein levels are rapidly increased but
decrease equally rapidly post-UVC treatment. This is consist-
ent with reports that in response to DNA damage, p21 levels
need to increase in order to establish a senescence-like growth
arrest and subsequently have to be down-regulated in order for
DNA repair to occur (34–36). One mechanism by which p21 is
down-regulated in response to UV-induced DNA damage has
been shown to involve ubiquitin-dependent proteolysis (36).
Here we show that p21mRNA levels also decrease in response
to UV irradiation, which is consistent with a study by Wang et
al. (37) that demonstrates that both p21 protein and mRNA
levels are down-regulated post-UV irradiation of MCF-7 cells.
Interestingly, we show that UVC irradiation leads to the
enhanced transcriptional repression of Tbx2 on the p21 pro-
moter, which raises the possibility that Tbx2may be required to
inhibit p21 in the UV-induced DNA-damaged pathway. This is
a particularly attractive possibility because to our knowledge no
other mechanism has yet been identified to explain how p21
mRNA levels are down-regulated following UV irradiation.
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